Exposure | Symptoms3-151(OR) | Hot QST3-152 (× effect) | Cold QST3-152 (× effect) | Vibration QST3-152 (× effect) |
Unadjusted for covariates: | ||||
DAYS | 3-1501.15 (1.04 to 1.26) | 0.99 (0.93 to 1.05) | 3-150 1.04 (1.00 to 1.09) | 3-1501.06 (1.01 to 1.12) |
OPEXP | 3-1501.13 (1.03 to 1.24) | 1.01 (0.95 to 1.07) | 3-1501.04 (1.01 to 1.09) | 3-1501.06 (1.01 to 1.12) |
Adjusted for covariates: | ||||
DAYS | 3-1501.13 (1.01 to 1.25) | 3-1500.94 (0.89 to 1.00) | 0.99 (0.95 to 1.03) | 1.01 (0.96 to 1.06) |
OPEXP | 3-1501.11 (1.01 to 1.23) | 0.96 (0.91 to 1.01) | 0.99 (0.96 to 1.03) | 1.01 (0.96 to 1.05) |
Adjusted for covariates excluding high leverage points:3-153 | ||||
DAYS | 1.07 (0.92 to 1.24) | 3-1500.92 (0.86 to 0.99) | 0.98 (0.94 to 1.03) | 1.03 (0.97 to 1.09) |
OPEXP | 1.06 (0.91 to 1.24) | 3-1500.93 (0.86 to 1.00) | 0.98 (0.93 to 1.03) | 1.04 (0.97 to 1.10) |
↵3-150 p<0.05.
↵3-151 Adjusted for age, country, and occupational group.
↵3-152 Adjusted for age, sex, country, and occupational group.
↵3-153 Omitting 4, 17, 10, and 18 data points for symptoms, hot, cold, and vibration QSTs respectively.
Variables DAYS and OPEXP represent cumulative exposure indices for exposure to OPs and days dipped, scaled by the interquartile range of the values across all subjects: 74 days for DAYS; and 2350 nmol.mmol−1.days for OPEXP.